| Controls | Patients with RA | ||||||
|---|---|---|---|---|---|---|---|
| Measure | Remission | LDA | MDA + HDA | p, RA vs Controls | Trend in RA Disease Activity | ||
| GSM | 94.69 (6.80) | CDAI | 96.09 (6.31) | 89.33 (4.52) | 74.78 (7.44) | 0.35 | 0.03 |
| 94.35 (6.71) | SDAI | 84.71 (6.51) | 93.74 (4.59) | 75.78 (6.77) | 0.33 | ||
| 94.96 (6.72) | DAS28 | 90.84 (4.65) | 101.82 (7.96) | 78.91 (5.48) | 0.09 | ||
| 95.78 (7.05) | CRP | 84.89 (5.25) | 88.13 (6.14) | 93.40 (7.14) | 0.31 | ||
| 96.41 (7.18) | ESR | 90.12 (6.96) | 86.80 (7.26) | 88.72 (4.89) | 0.87 | ||
| Minimum GSM | 88.38 (6.64) | CDAI | 89.50 (7.09) | 78.55 (5.11) | 65.99 (8.17) | 0.03 | |
| 88.01 (6.64) | SDAI | 78.18 (7.34) | 84.07 (5.27) | 66.13 (7.48) | 0.23 | 0.24 | |
| 88.11 (6.58) | DAS28 | 81.31 (5.23) | 94.23 (8.73) | 68.65 (6.22) | 0.11 | ||
| 89.33 (7.03) | CRP | 74.50 (6.05) | 82.94 (6.55) | 79.13 (8.38) | 0.63 | ||
| 89.33 (7.09) | ESR | 81.63 (7.32) | 79.64 (7.99) | 77.18 (5.71) | 0.63 | ||
| In area | 2.82 (0.12) | CDAI | 2.62 (0.11) | 2.75 (0.08) | 2.80(0.13) | 0.27 | |
| 2.82 (0.12) | SDAI | 2.74 (0.11) | 2.67 (0.08) | 2.85 (0.12) | 0.53 | 0.50 | |
| 2.81 (0.12) | DAS28 | 2.67 (0.08) | 2.83 (0.14) | 2.77 (0.09) | 0.41 | ||
| 2.78 (0.12) | CRP | 2.85 (0.09) | 2.59 (0.10) | 2.68 (0.12) | 0.23 | ||
| 2.83 (0.12) | ESR | 2.87 (0.12) | (0.12) 2.68 | 2.67 (0.08) | 0.54 | ||
CDAI: Clinical Disease Activity Index; SDAI: Simplified Disease Activity Index; DAS28: Disease Activity Score based on 28-joint counts; LDA: low disease activity; MDA: moderate disease activity; HDA: high disease activity; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.